LLS PedAL: Advancing Precision Medicine for Pediatric Acute Leukemia
Hear from visionary researchers who are working with The Leukemia & Lymphoma Society (LLS) to drive forward LLS PedAL, the first global precision medicine clinical trial for pediatric acute leukemia.
The Leukemia & Lymphoma Society (LLS) is leading an unprecedented collaboration to transform pediatric blood cancer treatment and care. LLS PedAL will test multiple novel therapies simultaneously at more than 200 clinical sites worldwide to bring safer, more effective treatments to children with relapsed acute leukemia. Through LLS PedAL, we will identify and validate underlying molecular drivers of disease and match patients with the most promising treatments based on their unique tumor biology. Ultimately, every child who enters the trial will receive screening to determine their specific biological markers.
LLS PedAL is at the heart of The LLS Childrenโs Initiative, a $100 million, multi-year endeavor to take on childhood blood cancer from every direction, including research, education and support, and advocacy. Our goal is to help children not only survive their cancer but thrive in their lives after treatment.
Learn more about The LLS Childrenโs Initiative: https://www.lls.org/childrens-initiative
Dive deeper into LLS PedAL: https://www.lls.org/childrens-initiative/pedal
Find free information and support: https://www.lls.org/childhood-blood-cancer
Stay up-to-date on the latest LLS news: https://www.lls.org/lls-newsnetwork
No comments found